All Names： Fingya，Gilomid，Finimod，Gilenya，fingolimod
Indications：multiple sclerosis (MS)
Customs Clearance Procedure：If the customs requires the package for customs clearance, please pay the customs clearance fee according to the content of EMS SMS and customs regulations.
INDICATIONS AND USAGE
GILENYA is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients 10 years of age and older.
Important Administration Instructions
Patients who initiate GILENYA, and those who reinitiate treatment after discontinuation for longer than 14 days, require first-dose monitoring. This monitoring is also recommended when the dose is increased in pediatric patients [see Dosage and Administration (2.4, 2.5)].
GILENYA can be taken with or without food.
In adults and pediatric patients 10 years of age and older weighing more than 40 kg, the recommended dosage of GILENYA is 0.5 mg orally once-daily.
In pediatric patients 10 years of age and older weighing less than or equal to 40 kg, the recommended dosage of GILENYA is 0.25 mg orally once daily.
Fingolimod doses higher than 0.5 mg are associated with a greater incidence of adverse reactions without additional benefit.
Bradyarrhythmia and Atrioventricular Blocks
Progressive Multifocal Leukoencephalopathy
Posterior Reversible Encephalopathy Syndrome
Severe Increase in Disability After Stopping GILENYA
Tumefactive Multiple Sclerosis
Increased Blood Pressure
Immune System Effects Following GILENYA Discontinuation
For full information, please refer to:
No information yet!!!